{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:40:17Z","timestamp":1775151617886,"version":"3.50.1"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,31]]},"DOI":"10.1097\/qad.0b013e3283553619","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T06:56:22Z","timestamp":1336028182000},"page":"1529-1533","source":"Crossref","is-referenced-by-count":35,"title":["Determinants of darunavir cerebrospinal fluid concentrations"],"prefix":"10.1097","volume":"26","author":[{"given":"Andrea","family":"Calcagno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylin","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Cusato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Simiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Siccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Marinaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"D\u2019Avolio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-10-20210130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/aid.2008.0216","article-title":"Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals.","volume":"25","author":"Yilmaz","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R4-10-20210130","doi-asserted-by":"crossref","first-page":"A99","DOI":"10.1016\/j.antiviral.2008.12.013","article-title":"The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.","volume":"82","author":"Varatharajan","year":"2009","journal-title":"Antiviral Res"},{"key":"R5-10-20210130","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1248\/bpb.32.1588","article-title":"P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.","volume":"32","author":"Fujimoto","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"R6-10-20210130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/FPC.0b013e328335b02d","article-title":"HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms.","volume":"20","author":"Hartkoorn","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"R7-10-20210130","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/00002030-200211220-00009","article-title":"Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs.","volume":"16","author":"Huisman","year":"2002","journal-title":"AIDS"},{"key":"R8-10-20210130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchromb.2007.10.003","article-title":"HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.","volume":"859","author":"DAvolio","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAD.0b013e3283553619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:33:40Z","timestamp":1620970420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201207310-00010"}},"subtitle":["impact of once-daily dosing and pharmacogenetics"],"short-title":[],"issued":{"date-parts":[[2012,7,31]]},"references-count":6,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283553619","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,31]]}}}